EYE PCR, a leader in the development of an endocapsular device that optimises intraocular lens (IOL) procedures, made a notable appearance at the European Society of Cataract and Refractive Surgeons (ESCRS) Congress in Barcelona. The company highlighted its innovative fixOflex technology as part of the special exhibition “75th IOL Anniversary Experience,” underlining its anticipated multitude benefits to optimized surgical outcomes.

A Milestone for Preservation of Capsular Form and Intracapsular Space During Replacement of the Natural Lens by an IOL.

During the special exhibition, “75th IOL Anniversary Experience”, EYE PCR showcased fixOflex as a key technological complementary device in IOL procedures. Unlike standalone IOL products, fixOflex works in conjunction with the overall lens implantation process to optimize surgical outcomes. Its primary function is to preserve the anatomical shape of the capsule and the intracapsular space, creating a stable platform for the lens. This provides multiple benefits during cataract and refractive lens exchange surgery.

Users Meeting and Collaborative Dinner

In addition to the technology showcase, EYE PCR hosted a successful “Users Meeting” at the congress, gathering ophthalmologists, surgeons, and other medical professionals to discuss best practices and real-world experiences using the company’s solution. This meeting provided valuable insights into how fixOflex technology supports the broader goal of improving surgical results in cataract and refractive lens exchange procedures.

To further build on these collaborations, EYE PCR held a “Dinner with the Collaborators,” where they engaged in discussions about future innovations and strengthening partnerships. The dinner allowed key collaborators and the company’s leadership to exchange ideas and chart a path for continued innovation in the field of ophthalmology.

Advancing Ophthalmic Care

EYE PCR’s presence at ESCRS Barcelona reinforced its commitment to delivering a cutting-edge solution. With fixOflex, the company provides surgeons with a definitive solution to complications associated with human lens capsule deformations following cataract and refractive lens exchange treatments.